Gestational Diabetes in Central Asia: Prevalence and Management

Evaluate prevalence and management of gestational diabetes in Tajikistan in two different settings (one rural and one urban).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gestational Diabetes Mellitus Diabetes Mellitus Diabetes, Gestational Endocrine System Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Pregnancy Complications Urogenital Diseases

Age range

18 year–55 year

Sex eligibility

Female

Study type

Observational

Primary location

Med. Dept. 2, University Munich

Munich, 81377, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

pregnancy

Exclusion criteria

known diabetes mellitus

Treatment and study plan

observation

Other

Primary outcomes

prevalence of gestational diabetes

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Ludwig-Maximilians - University of Munich

Other

Collaborators

German Federal Ministry of Education and Research
Helmholtz Zentrum München

Registry information

Acronym: GESDICA

Important dates

Study start: 2015
Primary completion: 2018
Study completion: 2018
First posted: May 7, 2015
Registry last updated: Feb 27, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed